Trial Profile
In patient without spleens or with poorly functioning ones does a newly licensed paediatric pneumococcal conjugate vaccine assist with preventing pneumococcal sepsis in preventing deaths or severe impairments (which are very costly) from overwhelming post splenectomy sepsis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms PAPI
- 08 Jun 2016 Status changed from recruiting to completed.
- 16 Aug 2011 New trial record